
Hookipa Biotech hires two officers
pharmafile | January 10, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | Farshad Guirakhoo, Hookipa, Thomas Monarth
Vaccines biotech firm Hookipa Biotech AG has appointed two new members to its management team.
Thomas Monath (pictured) joins as chief medical officer and Farshad Guirakhoo as chief scientific officer.
“We are very pleased to have Tom and Farshad join Hookipa,” said Dr Katherine Cohen, chief executive of Hookipa Biotech.
“Tom is a true vaccine veteran who has spearheaded the development of several market approved vaccines through his past work at CDC, Acambis and other companies, Farshad is an accomplished virologist and has spent more than two decades in both biotech and large pharma companies.”
Monath said: “I am extremely impressed with the technology platform being developed by Hookipa and look forward to working with the highly experienced team already assembled at the company.”
“I am very happy to join Hookipa Biotech, a dynamic company with a unique and very promising technology that can potentially be applied to a wide variety of infectious and non-infectious diseases,” added Guirakhoo.
Monath will play a key role in setting up Hookipa’s R&D strategies and product development processes, and is a former partner in the Pandemic and Biodefense Fund, Kleiner Perkins Caufield & Byers, and also Adjunct Professor at the Harvard School of Public Health.
Guirakhoo will be responsible for all aspects of research and development activities at Hookipa. Prior to joining the firm he held the position of senior director of External Research and Development at Sanofi Pasteur.






